This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1996 Aug 21;88(16):1093-5.

doi: 10.1093/jnci/88.16.1093.

Hormones and prostate cancer: where do we go from here?

PMID: 8757182
DOI: 10.1093/jnci/88.16.1093

Editorial

Hormones and prostate cancer: where do we go from here?

A W Hsing. J Natl Cancer Inst. 1996.

. 1996 Aug 21;88(16):1093-5.

doi: 10.1093/jnci/88.16.1093.

Author

PMID: 8757182
DOI: 10.1093/jnci/88.16.1093

No abstract available

PubMed Disclaimer

Comment on

Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Gann PH, et al. J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26. doi: 10.1093/jnci/88.16.1118. J Natl Cancer Inst. 1996. PMID: 8757191

Similar articles

Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Gann PH, et al. J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26. doi: 10.1093/jnci/88.16.1118. J Natl Cancer Inst. 1996. PMID: 8757191
5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.
Guess HA, Friedman GD, Sadler MC, Stanczyk FZ, Vogelman JH, Imperato-McGinley J, Lobo RA, Orentreich N. Guess HA, et al. Cancer Epidemiol Biomarkers Prev. 1997 Jan;6(1):21-4. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 8993793
Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Vatten LJ, et al. Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):967-9. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9367072
Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA, Wallace AM, Wu FC. Anderson RA, et al. J Clin Endocrinol Metab. 1996 Mar;81(3):902-8. doi: 10.1210/jcem.81.3.8772548. J Clin Endocrinol Metab. 1996. PMID: 8772548
Androgenic hormones and prostate cancer risk: status and prospects.
Gann PH. Gann PH. IARC Sci Publ. 2002;156:283-8. IARC Sci Publ. 2002. PMID: 12484188 Review. No abstract available.

See all similar articles

Cited by

Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.
Kehinde EO, Akanji AO, Memon A, Bashir AA, Daar AS, Al-Awadi KA, Fatinikun T. Kehinde EO, et al. Int Urol Nephrol. 2006;38(1):33-44. doi: 10.1007/s11255-005-3619-1. Int Urol Nephrol. 2006. PMID: 16502050
The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patients.
Reyes-Hernández OD, Vega L, Jiménez-Ríos MA, Martínez-Cervera PF, Lugo-García JA, Hernández-Cadena L, Ostrosky-Wegman P, Orozco L, Elizondo G. Reyes-Hernández OD, et al. PLoS One. 2014 Jun 12;9(6):e99974. doi: 10.1371/journal.pone.0099974. eCollection 2014. PLoS One. 2014. PMID: 24924803 Free PMC article.
Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men.
Trabert B, Graubard BI, Nyante SJ, Rifai N, Bradwin G, Platz EA, McQuillan GM, McGlynn KA. Trabert B, et al. Cancer Causes Control. 2012 Dec;23(12):1881-91. doi: 10.1007/s10552-012-0024-9. Epub 2012 Sep 28. Cancer Causes Control. 2012. PMID: 23053790 Free PMC article. Clinical Trial.
Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.
Menegaux F, Anger A, Randrianasolo H, Mulot C, Laurent-Puig P, Iborra F, Bringer JP, Leizour B, Thuret R, Lamy PJ, Rébillard X, Trétarre B; EPICAP Study Group. Menegaux F, et al. BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106. BMC Cancer. 2014. PMID: 24552491 Free PMC article.
Novel biomarkers for risk of prostate cancer: results from a case-control study.
Yang L, Gaikwad NW, Meza J, Cavalieri EL, Muti P, Trock B, Rogan EG. Yang L, et al. Prostate. 2009 Jan 1;69(1):41-8. doi: 10.1002/pros.20850. Prostate. 2009. PMID: 18816637 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information